Tuberculosis Testing Market is Expected to Ascend at Around 4.0% CAGR, Exceeding a Valuation of Around US$ 3,399.8 Million by 2027- TMR Report

According to Transparency Market Research's latest report on the global 𝐭𝐮𝐛𝐞𝐫𝐜𝐮𝐥𝐨𝐬𝐢𝐬 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 for the historical period 2017-2018 and forecast period 2019-2027, Increase in the case detection rate worldwide, Rise in the prevalence of drug-resistant tuberculosis infection, Improvement in bacteriological confirmation, Rise in awareness enabling proper management of the disease, Rising demand for improved and technologically advanced tuberculosis testing procedures and Tuberculosis awareness and control programs are projected to drive the global tuberculosis testing Market during the forecast period.

Tuberculosis testing market to Reach US$ 3,399.8 Mn By 2027. is anticipated to expand at a CAGR of 4.0% from 2019 to 2027.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2267&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

The Case Detection Rate (CDR) offers an approximate indication of the percentage of all newly occurring cases of tuberculosis (TB) that have been diagnosed through recommended tests and reported to the national surveillance or tuberculosis program (NTP).

To calculate the CDR for a country, one would divide the total number of newly reported cases of tuberculosis, including relapses, by the estimated total number of incident cases for the same year. This ratio is then expressed as a percentage. The CDR is a crucial metric for understanding the proportion of new TB cases that are identified through diagnosis each year within a specific country.

According to the "Global Tuberculosis Report" published by the World Health Organization (WHO) in 2015, it was estimated that approximately 10.4 million new TB cases occurred worldwide.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Thermo Fisher Scientific, Inc.,Alere, Inc.,Becton,Dickinson and Company,F. Hoffmann-La Roche AG,LIONEX Diagnostics & Therapeutics GmbH,Danaher Corporation,Danaher Corporation,Creative Diagnostics,QIAGEN,Hain Lifescience GmbH.,Oxford Immunotec Ltd.,Hologic, Inc.,Cepheid,Akonni Biosystems, Inc.,bioMerieux SA,Epistem Ltd.,among others

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐓𝐞𝐬𝐭 𝐓𝐲𝐩𝐞

Chest X-ray
Culture-based Tests
Interferon-Gamma Release Assay (IGRA)
Mantoux Test (TST)
Nucleic Acid Testing (NAT), Xpert test
Serological Tests
Smear Microscopy
Other Tests (ADA, etc.)

𝐄𝐧𝐝-𝐮𝐬𝐞𝐫

Academics and Research
Hospitals Laboratories
Physician's Office Laboratories
Reference Laboratories
Others (Home Health Agencies, etc.)

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

The Thermo Fisher Scientific, Inc. offers wide range of product portfolio ranging from analytical instruments, automation, robotics, and life science research consumables to clinical diagnostics.

The Thermo Fisher Scientific, Inc., more than 40 products are being marketed exclusively for tuberculosis detection, diagnosis, isolation, and identification from a variety of samples such as blood, sputum, urine, tissue, and sterile body fluids

By Thermo Fisher Scientific, Inc., for instance, VersaTREK microbial detection system offered by company, enables fully automated detection of mycobacteria from all samples or specimens types. It is also possible to perform accurate Mycobacterium tuberculae susceptibility assays with the same system.

Alere, Inc. focuses on enhancing its market presence in developing economies by setting up direct sales channels. In early 2015, the company set up a sales unit in India for effective product sales.

Becton, Dickinson and Company launches innovative new products to expand its presence globally. The company conducts its research & development activities in North America, China, France, India, Ireland, and Singapore. It spent approximately US$ 828 Mn on research & development in 2016.

BD offers a wide range of products for mycobacterial growth and testing requirements, as well as provides training, technical advice, and services from specimen collection to reporting.

F. Hoffmann-La Roche AG is focused on developing new products for the treatment of cancer and respiratory diseases. The company constantly works on improving the product efficiency and patient care. The company has initiated new strategic programs for Africa.

Lionex produces, preserves, authenticates, and distributes standard reference microorganisms, diagnostic kits, recombinant proteins, and other materials to public and private sectors and scientific research communities across the world.

𝐏𝐥𝐚𝐜𝐞 𝐚𝐧 𝐎𝐫𝐝𝐞𝐫 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.transparencymarketresearch.com/checkout.php?rep_id=2267<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬:

𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

Rising prevalence of TB globally
Technological advancements in diagnostic techniques
Government initiatives for TB control programs
Growing awareness among the populace

𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬:

Lack of infrastructure in rural areas
Limited access to advanced diagnostic tools in low-income regions
Presence of counterfeit diagnostic products

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Adoption of point-of-care testing for rapid diagnosis
Integration of artificial intelligence and machine learning in TB diagnostics
Increasing focus on multiplex testing for simultaneous detection of TB and other respiratory infections

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The tuberculosis testing market is poised for significant expansion, driven by ongoing research and development efforts, strategic collaborations, and the introduction of innovative diagnostic technologies. With a growing emphasis on precision medicine and personalized healthcare, the market is expected to witness a surge in demand for accurate and efficient TB testing solutions.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Analysis of market dynamics including drivers, challenges, and trends
Assessment of market segmentation and regional trends
Evaluation of competitive landscape and key players
Examination of recent developments and technological advancements

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐄𝐱𝐨𝐬𝐨𝐦𝐞 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/05/2662523/0/en/Exosome-Technologies-Market-Value-to-Reach-USD-343-5-Mn-by-2031-rising-at-a-CAGR-of-24-8-TMR-Study.html

𝐏𝐫𝐢𝐧𝐭𝐞𝐝 𝐚𝐧𝐝 𝐅𝐥𝐞𝐱𝐢𝐛𝐥𝐞 𝐒𝐞𝐧𝐬𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/05/2662384/0/en/Printed-and-Flexible-Sensors-Market-Revenue-is-Expected-to-Grow-at-a-Valuation-US-4-1-Billion-in-2031-Transparency-Market-Research-Inc.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com      
Email:  sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.